细胞库外包市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按类型、按细胞类型、按阶段、按公司和按地区划分

在2023-2027年的预测期内，全球细胞库外包市场预计将出现令人瞩目的增长。主要因素包括慢性病的增加，父母人口意识的提高，以及老年人口的增加，这些都推动了市场的增长。细胞库外包是一种储存特定基因组细胞的能力，用于未来的目的。细胞库外包可以用来制作完整的细胞系特征，也可以帮助减少细胞系的交叉污染。支持市场增长的其他因素有：对研究和开发（R&D）活动的广泛投资，扩大临床试验的数量，对干细胞疗法和基因疗法的需求上升，与干细胞应用有关的研究活动增加，对生物制品的需求增加，先进的保存技术的发展，大量的临床试验，以及医疗保健行业的扩张，都支持了市场的增长。此外,市场参与者越来越多地采用合作和收购策略,也支持市场的增长。

慢性病发病率的上升和老年人口的增加

全球范围内慢性疾病，如糖尿病、心血管疾病和其他疾病的发生率不断增加，正在加强市场的增长。根据世界卫生组织的数据，心血管疾病（CVDs）是全球死亡的主要原因，每年约有1790万人死亡。干细胞被用来治疗各种慢性疾病，因为这些疾病因其不良影响而无法用传统方法治疗。因此，使用干细胞治疗作为治疗剂，有助于减少治疗带来的风险或损害。由于患有这些致命疾病的人数不断增加，对干细胞疗法和基因疗法的需求正在上升，这推动了市场的增长。

越来越多的老年人口支持市场的发展

世界各地老年人口基数的增加,使干细胞疗法的需求激增,从而推动了市场的增长。根据世界卫生组织(WHO)的数据,老年人口,即60岁及以上人口的数量和比例正在增加。2019年，60岁及以上的人的数量为10亿。这个数字到2030年可能会上升到14亿，到2050年可能会达到21亿。

对干细胞银行的认识不断提高

各个新兴国家对干细胞银行的认识不断提高,促进了该市场的增长。如今,人们越来越意识到干细胞储存对未来的好处。由于健康专家开始教育他们储存干细胞的意义和好处,父母和孕妇的意识也越来越强,推动了全球市场的增长。例如，在美国，捐赠者登记处包含了超过900万的潜在捐赠者。此外，捐赠者登记处包括26.6万个脐带血单位，其中11.5万个单位来自国家脐带血库存（NCBI），2021年将有超过4000个NCBI单位加入。

可用的定制服务

利用给定的市场数据，TechSci Research根据公司的具体需求提供定制服务。该报告有以下定制选项：

公司信息

• 对其他市场参与者（最多5家）的详细分析和剖析。

目录

第一章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19对全球细胞银行外包市场的影响

第五章：客户的声音

第六章：全球细胞银行外包市场前景

• 市场规模和预测
  • 按价值
• 市场份额和预测
  • 按类型（主细胞库、工作细胞库、病毒细胞库）
  • 按细胞类型（干细胞和/或非干细胞）分类
  • 按阶段（库房储存、库房特征和测试、库房准备）分类
  • 按公司分类（2021年）
  • 按地区
• 市场地图

第7章：北美细胞银行外包市场前景

• 市场规模和预测
  • 按价值
• 市场份额和预测
  • 按类型
  • 按细胞类型
  • 按阶段分类
  • 按国家分类
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第8章：欧洲细胞银行外包市场前景

• 市场规模和预测
  • 按价值
• 市场份额与预测
  • 按类型
  • 按细胞类型
  • 按阶段分类
  • 按国家分类
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第九章：亚太地区细胞银行外包市场前景

• 市场规模和预测
  • 按价值
• 市场份额与预测
  • 按类型
  • 按细胞类型
  • 按阶段分类
  • 按国家分类
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第十章：南美细胞银行外包市场展望

• 市场规模和预测
  • 按价值
• 市场份额与预测
  • 按类型
  • 按细胞类型
  • 按阶段分类
  • 按国家分类
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第11章 ：中东和非洲细胞银行外包市场展望

• 市场规模和预测
  • 按价值
• 市场份额和预测
  • 按类型
  • 按细胞类型
  • 按阶段分类
  • 按国家分类
• MEA: 国家分析
  • 南非 细胞银行外包
  • 沙特阿拉伯细胞银行业务外包
  • 阿联酋细胞银行业务外包
  • 土耳其细胞银行业务外包
  • 埃及细胞银行业务外包

第十二章 ：市场动态

• 驱动力
• 挑战

第十三章 ：市场趋势与发展

第十四章：竞争格局

• Cryo-Cell International, Inc. Charles River Laboratories International, Inc.Goodwin Biotechnology Inc.Lonza Group AG SGS Life Sciences (SGS SA) Global Stem Inc.BSL Bioservice Scientific Laboratories GmbH BioReliance Corporation

第十五章：战略建议

The global cell banking outsourcing market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include the increase in chronic diseases, rising awareness among the parental population, and the rise in the geriatric population, which are propelling the growth of the market. Cell banking outsourcing is an ability that stores cells of a particular genome for future purposes. Cell banking outsourcing can be used to produce complete characterizations of cell lines and can also help to reduce the cross-contamination of a cell line. The other factors supporting the market's growth are extensive investments in research and development (R&D) activities, expanding the number of clinical trials, rising demand for stem cell therapies and gene therapies, rise in research activities related to stem cell applications, increasing demand for biologic products, development of advanced preservation techniques, a large number of clinical trials, and expansion of healthcare industry are bolstering the growth of the market. Also, the growing adoption of collaboration and acquisition strategies by the market players is supporting the growth of the market.

Rising Prevalence of Chronic Diseases and Increasing Geriatric Population

The increasing occurrence of chronic diseases, such as diabetes, cardiovascular diseases, and others, across the globe is strengthening the growth of the market. According to the WHO, Cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking approximately 17.9 million lives each year. Stem cells are used to treat various chronic diseases as these diseases cannot be treated with traditional methods due to their adverse effect. Therefore, the use of stem cell therapy for the treatment act as a healing agent, which helps to reduce the risk or damage caused by the treatment. Owing to the continuous rise in the number of people suffering from these fatal diseases, the demand for stem cell therapies and gene therapies is rising, which is driving the growth of the market.

Increasing Geriatric Population Supports the Market

The rise in the geriatric population base across the world is surging the demand for stem cell therapy, which is impelling the growth of the market. According to the World Health Organization (WHO) data, the number and proportion of the elderly population, meaning people with age 60 years and above in the population is increasing. In 2019, the number of people aged 60 years and above was 1 billion. This number is likely to rise to 1.4 billion by 2030 and 2.1 billion by 2050.

Growing Awareness About Stem Cell Banking

Growing awareness about stem cell banking across various emerging countries is augmenting the growth of the market. Nowadays, people are becoming more aware of the benefits of stem cell banking for future purposes. Parental as well as expectant populations are becoming more aware as health specialists are starting to educate them about the significance and advantages of storing stem cells which are fueling the growth of the market globally. For instance, in the United States, the donor registry contains above 9 million potential donors. In addition, the donor registry includes 266,000 cord blood units, of which 115,000 units are from the National Cord Blood Inventory (NCBI), with over 4000 NCBI units added in 2021.

Market Segmentation

The global cell banking outsourcing market is segmented into type, cell type, Phase, and company. Based on type, the market is divided into master cell banking, working cell banking, and viral cell banking. Based on cell type, the market is divided into stem cells and non-stem cells. Based on Phase, the market is divided into bank storage, bank characterization & testing, and bank preparation. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the growing prevalence of chronic and genetic disorders in the country.

Market Players

Cryo-Cell International, Inc, Charles River Laboratories International, Inc., Goodwin Biotechnology Inc., Lonza Group AG, SGS Life Sciences (SGS SA), Global Stem Inc., BSL Bioservice Scientific Laboratories GmbH, and BioReliance Corporation are some of the leading companies operating in the market.

Report Scope

In this report, global cell banking outsourcing market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Cell Banking Outsourcing Market, By type:

• Master Cell Banking
• Working Cell Banking
• Viral Cell Banking

Cell Banking Outsourcing Market, By Cell Type:

• Stem Cell
• Non-Stem Cell

Cord Blood Banking, By Phase:

• Bank Storage
• Bank Characterization & Testing
• Bank Preparation

Cell Banking Outsourcing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea

• Europe & CIS
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Cell Banking Outsourcing Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Cell Banking Outsourcing Market

5. Voice of Customer

6. Global Cell Banking Outsourcing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking)
  • 6.2.2. By Cell Type (Stem Cell v/s Non-Stem Cell)
  • 6.2.3. By Phase (Bank Storage, Bank Characterization & Testing, Bank Preparation)
  • 6.2.4. By Company (2021)
  • 6.2.5. By Region
• 6.3. Market Map

7. North America Cell Banking Outsourcing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Cell Type
  • 7.2.3. By Phase
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Cell Banking Outsourcing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Cell Type
      • 7.3.1.2.3. By Phase
  • 7.3.2. Canada Cell Banking Outsourcing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Cell Type
      • 7.3.2.2.3. By Phase
  • 7.3.3. Mexico Cell Banking Outsourcing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Cell Type
      • 7.3.3.2.3. By Phase

8. Europe Cell Banking Outsourcing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Cell Type
  • 8.2.3. By Phase
  • 8.2.4. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Cell Banking Outsourcing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Cell Type
      • 8.3.1.2.3. By Phase
  • 8.3.2. Germany Cell Banking Outsourcing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Cell Type
      • 8.3.2.2.3. By Phase
  • 8.3.3. United Kingdom Cell Banking Outsourcing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Cell Type
      • 8.3.3.2.3. By Phase
  • 8.3.4. Italy Cell Banking Outsourcing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Cell Type
      • 8.3.4.2.3. By Phase
  • 8.3.5. Spain Cell Banking Outsourcing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Cell Type
      • 8.3.5.2.3. By Phase

9. Asia-Pacific Cell Banking Outsourcing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Cell Type
  • 9.2.3. By Phase
  • 9.2.4. By Country
• 9.3. Asia-Pacific: Country Analysis
  • 9.3.1. China Cell Banking Outsourcing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Cell Type
      • 9.3.1.2.3. By Phase
  • 9.3.2. India Cell Banking Outsourcing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Cell Type
      • 9.3.2.2.3. By Phase
  • 9.3.3. Japan Cell Banking Outsourcing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Cell Type
      • 9.3.3.2.3. By Phase
  • 9.3.4. South Korea Cell Banking Outsourcing Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By Cell Type
      • 9.3.4.2.3. By Phase
  • 9.3.5. Australia Cell Banking Outsourcing Market Outlook
    • 9.3.5.1. Market Size & Forecast
      • 9.3.5.1.1. By Value
    • 9.3.5.2. Market Share & Forecast
      • 9.3.5.2.1. By Type
      • 9.3.5.2.2. By Cell Type
      • 9.3.5.2.3. By Phase

10. South America Cell Banking Outsourcing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Cell Type
  • 10.2.3. By Phase
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cell Banking Outsourcing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Cell Type
      • 10.3.1.2.3. By Phase
  • 10.3.2. Argentina Cell Banking Outsourcing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Cell Type
      • 10.3.2.2.3. By Phase
  • 10.3.3. Colombia Cell Banking Outsourcing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Cell Type
      • 10.3.3.2.3. By Phase

11. Middle East and Africa Cell Banking Outsourcing Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Type
  • 11.2.2. By Cell Type
  • 11.2.3. By Phase
  • 11.2.4. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Cell Banking Outsourcing Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Type
      • 11.3.1.2.2. By Cell Type
      • 11.3.1.2.3. By Phase
  • 11.3.2. Saudi Arabia Cell Banking Outsourcing Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Type
      • 11.3.2.2.2. By Cell Type
      • 11.3.2.2.3. By Phase
  • 11.3.3. UAE Cell Banking Outsourcing Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Type
      • 11.3.3.2.2. By Cell Type
      • 11.3.3.2.3. By Phase
  • 11.3.4. Turkey Cell Banking Outsourcing Market Outlook
    • 11.3.4.1. Market Size & Forecast
      • 11.3.4.1.1. By Value
    • 11.3.4.2. Market Share & Forecast
      • 11.3.4.2.1. By Type
      • 11.3.4.2.2. By Cell Type
      • 11.3.4.2.3. By Phase
  • 11.3.5. Egypt Cell Banking Outsourcing Market Outlook
    • 11.3.5.1. Market Size & Forecast
      • 11.3.5.1.1. By Value
    • 11.3.5.2. Market Share & Forecast
      • 11.3.5.2.1. By Type
      • 11.3.5.2.2. By Cell Type
      • 11.3.5.2.3. By Phase

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

• 14.1. Cryo-Cell International, Inc
• 14.2. Charles River Laboratories International, Inc.
• 14.3. Goodwin Biotechnology Inc.
• 14.4. Lonza Group AG
• 14.5. SGS Life Sciences (SGS SA)
• 14.6. Global Stem Inc.
• 14.7. BSL Bioservice Scientific Laboratories GmbH
• 14.8. BioReliance Corporation

15. Strategic Recommendations